Sanofi Obesity Drug Can Cause Mood Disorders: Study
Sanofi-Aventis' plans to market its weight-loss drug Zimulti in the United States took another hit this week, with two new studies finding that the drug increases the risk of developing psychiatric...To view the full article, register now.
Already a subscriber? Click here to view full article